NO820967L - Fremgangsmaate ved fremstilling av nye terapeutisk virksomme peptider. - Google Patents

Fremgangsmaate ved fremstilling av nye terapeutisk virksomme peptider.

Info

Publication number
NO820967L
NO820967L NO820967A NO820967A NO820967L NO 820967 L NO820967 L NO 820967L NO 820967 A NO820967 A NO 820967A NO 820967 A NO820967 A NO 820967A NO 820967 L NO820967 L NO 820967L
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutically effective
new therapeutically
effective peptides
Prior art date
Application number
NO820967A
Other languages
English (en)
Other versions
NO162024C (no
NO162024B (no
Inventor
Maurice Manning
Wilbur Henderson Sawyer
Original Assignee
Ohio Med College
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/247,008 external-priority patent/US4367225A/en
Application filed by Ohio Med College, Univ Columbia filed Critical Ohio Med College
Publication of NO820967L publication Critical patent/NO820967L/no
Publication of NO162024B publication Critical patent/NO162024B/no
Publication of NO162024C publication Critical patent/NO162024C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO820967A 1981-03-24 1982-03-23 Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme peptider. NO162024C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/247,008 US4367225A (en) 1981-03-24 1981-03-24 Novel antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin
US06/322,071 US4399125A (en) 1981-03-24 1981-11-16 Novel antagonists of the antidiuretic action of arginine vasopressin

Publications (3)

Publication Number Publication Date
NO820967L true NO820967L (no) 1982-09-27
NO162024B NO162024B (no) 1989-07-17
NO162024C NO162024C (no) 1989-10-25

Family

ID=26938391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820967A NO162024C (no) 1981-03-24 1982-03-23 Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme peptider.

Country Status (21)

Country Link
US (1) US4399125A (no)
EP (1) EP0061356B1 (no)
KR (1) KR880000758B1 (no)
AU (1) AU546865B2 (no)
BG (1) BG38487A3 (no)
CA (1) CA1185235A (no)
DD (2) DD212735A5 (no)
DE (1) DE3264734D1 (no)
DK (1) DK130182A (no)
ES (2) ES8604264A1 (no)
FI (1) FI77047C (no)
HU (1) HU189127B (no)
IE (1) IE52624B1 (no)
IL (1) IL65211A (no)
NO (1) NO162024C (no)
NZ (1) NZ199908A (no)
PH (1) PH19237A (no)
PT (1) PT74615B (no)
RO (1) RO84361B (no)
YU (1) YU63482A (no)
ZW (1) ZW4882A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491577A (en) * 1981-11-16 1985-01-01 The Medical College Of Ohio Antagonists of the antidiuretic action of arginine vasopressin
DK153883A (da) * 1982-04-20 1983-10-21 Ceskoslovenska Akademie Ved Vasopressin-analoge
US4469679A (en) * 1983-02-16 1984-09-04 Smithkline Beckman Corporation Octapeptide vasopressin antagonists
US4587045A (en) * 1983-02-16 1986-05-06 Smithkline Beckman Corporation Intermediates for preparing octapeptide vasopressin antagonists
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
CA1238314A (en) * 1983-09-22 1988-06-21 James F. Callahan Process for preparing basic heptapeptide vasopressin antagonists
US4551445A (en) * 1983-10-14 1985-11-05 The Medical College Of Ohio Derivatives of arginine vasopressin antagonists
US4714696A (en) * 1984-01-26 1987-12-22 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
US4649130A (en) * 1984-01-26 1987-03-10 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
US4481194A (en) * 1984-03-07 1984-11-06 Smithkline Beckman Corporation Des-proline-des-glycine vasopressin antagonists
US4481193A (en) * 1984-03-07 1984-11-06 Smithkline Beckman Corporation Des-proline vasopressin antagonists
PH21037A (en) * 1984-03-07 1987-06-30 Smithkline Beckman Corp Des-proline vasopressin antagonists
US4597901A (en) * 1984-12-14 1986-07-01 Smithkline Beckman Corporation β-indolylalanyl or β-indolylglycinyl vasopressin antagonists
US4719199A (en) * 1984-12-14 1988-01-12 Smithkline Beckman Corporation Diuretic compositions and methods of producing diuresis
US4684716A (en) * 1984-12-14 1987-08-04 Smithkline Beckman Corporation Polypeptide intermediates
US4624943A (en) * 1985-03-20 1986-11-25 Smithkline Beckman Corporation Aromatic basic-tailed vasopressin antagonists
EP0247033A1 (en) * 1985-10-25 1987-12-02 Gibson-Stephens Neuropharmaceuticals, Inc. Conformationally constrained oxytocin antagonists with prolonged biological activities
PT84342B (pt) * 1986-02-25 1989-09-14 Smithkline Beecham Corp Processo de preparacao de compostos de vasopressina
US4762820A (en) * 1986-03-03 1988-08-09 Trustees Of Boston University Therapeutic treatment for congestive heart failure
WO1988005661A1 (en) * 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Vasopressin-based pharmaceutical compositions
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
AT398766B (de) * 1988-05-26 1995-01-25 Gebro Broschek Gmbh Verfahren zur intramolekularen oxidation von zwei -sh gruppen in einer peptidverbindung zu einer disulfidbrücke
US5070187A (en) * 1989-11-03 1991-12-03 Trustees Of Boston University Pharmacologically effective antagonists of arginine-vasopressin
US5051400A (en) * 1990-06-28 1991-09-24 Smithkline Beecham Corporation Method of treating nausea and emesis related to motion sickness with vasopressin antagonists
CN111253569B (zh) * 2020-02-26 2021-06-01 山东大学 一种聚合物、其制剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1193509B (de) * 1960-06-02 1965-05-26 Hoechst Ag Verfahren zur Herstellung eines neuen Oktapeptids mit vasopressorischer Wirksamkeit
CH426861A (de) * 1963-06-06 1966-12-31 Sandoz Ag Verfahren zur Herstellung eines bisher unbekannten Polypeptids
CH442342A (de) * 1964-07-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Polypeptids
CH460039A (de) * 1965-04-15 1968-07-31 Sandoz Ag Verfahren zur Herstellung eines neuen Polypeptids
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4148787A (en) * 1976-05-24 1979-04-10 Ferring Ab Antidiuretically effective polypeptide and a process for preparing the same

Also Published As

Publication number Publication date
ZW4882A1 (en) 1983-02-23
EP0061356A3 (en) 1982-12-29
PT74615A (en) 1982-04-01
NO162024C (no) 1989-10-25
US4399125A (en) 1983-08-16
IL65211A (en) 1986-02-28
AU8161782A (en) 1982-09-30
FI77047B (fi) 1988-09-30
YU63482A (en) 1985-10-31
IL65211A0 (en) 1982-05-31
DD202695A5 (de) 1983-09-28
EP0061356A2 (en) 1982-09-29
KR880000758B1 (ko) 1988-05-06
FI77047C (fi) 1989-01-10
AU546865B2 (en) 1985-09-26
IE820465L (en) 1982-09-24
ES8604264A1 (es) 1986-01-16
ES546137A0 (es) 1987-03-01
PH19237A (en) 1986-02-14
EP0061356B1 (en) 1985-07-17
DK130182A (da) 1982-09-25
ES8703489A1 (es) 1987-03-01
KR830008683A (ko) 1983-12-14
ES510579A0 (es) 1986-01-16
DE3264734D1 (en) 1985-08-22
NZ199908A (en) 1985-09-13
RO84361B (ro) 1984-07-30
FI821019A0 (fi) 1982-03-23
PT74615B (en) 1983-10-20
FI821019L (fi) 1982-09-25
IE52624B1 (en) 1988-01-06
HU189127B (en) 1986-06-30
CA1185235A (en) 1985-04-09
BG38487A3 (en) 1985-12-16
DD212735A5 (de) 1984-08-22
RO84361A (ro) 1984-05-23
NO162024B (no) 1989-07-17

Similar Documents

Publication Publication Date Title
NO820967L (no) Fremgangsmaate ved fremstilling av nye terapeutisk virksomme peptider.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO157177C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme muramylpeptider.
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO160780C (no) Analogifremgangsmaate ved fremstilling av substituerte iminodisyrer.
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO158752C (no) Fremgangsmaate til fremstilling av etanol.
NO823520L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive carbohydrater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO820281L (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider
NO156865C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO833521L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk virksomme vinylthioacetamido-oxacefalosporinderivater
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.
NO160203C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fenotiazin-forbindelser.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO831012L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-beta-d-ribofuranosylselenazol-4-carboxamid
NO153100C (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider.
NO153258C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner
NO153730C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 10-brom-e-homo-eburnan.
NO156751B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive p-oxooxazolidinylbenzensulfonamider.
NO160513C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner.
NO862676D0 (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme benzamider.
NO166231C (no) Fremgangsmaate ved fremstilling av carboxyalkyldipeptider.